US Food and Drug Administration review divisions are not being pushed to require advisory committee votes or only discussions, just to ensure that staff obtain the input they need to decide on pending applications.
As part of advisory committee reform efforts, FDA officials have been writing internal documents outlining best practices for determining when...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?